Support our Foundation of Myology project
ARISE-JANSSEN
A phase 2/3, multicentre, multi-stage, randomised, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of nipocalimab in adults with chronic inflammatory demyelinating polyneuropathy (CIDP).